EVZIO2YOU Direct-deliveryService

Get EVZIO to your patients through

Committed to affordability

Committed to affordability

  • Through the EVZIO2YOU direct-delivery service, no other naloxone product, branded or generic, is more affordable than EVZIO for commercially insured patients
  • All commercially insured patients pay absolutely nothing out of pocket, regardless of coverage, copays, or deductible payments

THIS OFFER IS NOT INSURANCE. This offer is valid only in the United States. Program is applicable only for commercially insured patients who utilize the direct delivery service. Offer not valid for patients insured in whole or in part by government programs such as Medicaid, Medicare, Tricare or other federal or state health programs (such as state prescription drug programs). If the patient is eligible for benefits under any such program, the patient cannot use this offer. By using this offer, the patient certifies that he or she will comply with any terms of his or her health insurance contract requiring notification to his or her payer of the existence and/or value of this offer. It is illegal to (or offer to) sell, purchase, or trade this offer. This offer is not transferable. Cannot be combined with any rebate/coupon, free trial, or similar offer for the specified prescription(s). Void where prohibited by law. Cash discount cards are not commercial payers and are not eligible to be used for this program. Kaleo, Inc. reserves the right to rescind, revoke, amend, or terminate this offer without written notice at any time. Savings limits apply. Call (877) 438-9463 for questions regarding eligibility.

Ease of fulfillment

Ease of fulfillment

  • Enrollment is as simple as providing a prescription and demographic information. The pharmacy, which is trained on the EVZIO2YOU access program, ensures that the prescription is processed quickly and properly
  • The direct-delivery service delivers EVZIO to the patient’s home or to your office with free shipping
Comprehensive naloxone access

Comprehensive naloxone access

  • Many patients with government insurance may get EVZIO at no cost. If the patient decides the cost is not affordable, the pharmacy may work with the patient’s healthcare provider to offer an alternative naloxone

Find a Pharmacy

Our goal is to help ensure that your patients and their care partners have access to naloxone.

Map

EVZIO fulfillment through EVZIO2YOU direct-delivery service

EVZIO fulfillment through EVZIO2YOU direct-delivery service

For questions about EVZIO2YOU, call 1-855-77-EVZIO (1-855-773-8946) Monday through Saturday, 8 am to 8 pm ET

INDICATION

EVZIO is an opioid antagonist indicated for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression in adults and pediatric patients. EVZIO is intended for immediate administration as emergency therapy in settings where opioids may be present. EVZIO is not a substitute for emergency medical care.

IMPORTANT SAFETY INFORMATION

EVZIO is contraindicated in patients known to be hypersensitive to naloxone hydrochloride or to any of the ingredients in EVZIO.

Seek emergency medical assistance immediately after use. Additional supportive and/or resuscitative measures may be helpful while awaiting emergency medical assistance.

The following warnings and precautions should be taken when administering EVZIO:

The following adverse reactions were most commonly observed in EVZIO clinical studies: dizziness and injection site erythema.

Abrupt reversal of opioid effects in persons who were physically dependent on opioids has precipitated signs and symptoms of opioid withdrawal including: body aches, fever, sweating, runny nose, sneezing, piloerection, yawning, weakness, shivering or trembling, nervousness, restlessness or irritability, diarrhea, nausea or vomiting, abdominal cramps, increased blood pressure, and tachycardia. In the neonate, opioid withdrawal signs and symptoms also included: convulsions, excessive crying, and hyperactive reflexes.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please click for full Prescribing Information and Patient Information.

INDICATION

EVZIO is an opioid antagonist indicated for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression in adults and pediatric patients. EVZIO is intended for immediate administration as emergency therapy in settings where opioids may be present. EVZIO is not a substitute for emergency medical care.

IMPORTANT SAFETY INFORMATION

EVZIO is contraindicated in patients known to be hypersensitive to naloxone hydrochloride or to any of the ingredients in EVZIO.